Cisplatin-induced hypocalcemia and hypomagnesemia
- 1 November 1980
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 140 (11) , 1513-1514
- https://doi.org/10.1001/archinte.140.11.1513
Abstract
Cisplatin (cis-diamminedichloroplatinum), a chemotherapeutic agent active against solid tumors, is a known cause of acute renal failure and renal tubular dysfunction. A case of renal magnesium wasting and hypomagnesemia in a 58 yr old women with genital pelvic malignancy was seen. Her initial manifestation was that of chronic symptomatic hypocalcemia of 4 mo. duration. The relatively reduced parathyroid hormone level in this patient and the possible sites of cisplatin-induced renal tubular dysfunction resulting in hypermagnesuria were evaluated. The importance of serially observing cisplatin-treated patients for the possible development of hypomagnesemic hypocalcemia is emphasized.This publication has 1 reference indexed in Scilit:
- Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving CisplatinAnnals of Internal Medicine, 1979